Recognitions

“Aragen has been a valued collaborator of FMC for several years. This partnership extends across multiple disciplines in research and development and we appreciate our strong working relationship.”

“Aragen is well positioned to benefit from the secular trend of increased outsourcing by the life sciences industry. With a clear value creation plan in place, we look forward to closely working with the management and shareholders of Aragen. Goldman Sachs is actively seeking to invest and foster leading, national champions of India who are building companies of a global scale.”

“Developing a variety of vaccine alternatives is critical to bringing the SARS-Cov-2 pandemic under control. Utilizing the technology created at NIH with Aragen’s pre-clinical development capabilities will help us accelerate the development of the TerraCov2 vaccine candidate. We believe the relationship between the companies will result in advancement of the vaccine candidate into the clinic as rapidly as possible,”